Video Library
Nursing Interventions
Nursing Interventions ( 4 Questions)
A nurse is preparing to administer chemotherapy to a patient who has lung cancer. Which of the following laboratory tests should the nurse review before giving the chemotherapy drugs?
The nurse should review the complete blood count and differential before administering chemotherapy to a patient who has lung cancer. The complete blood count and differential measure the number and types of blood cells, such as red blood cells, white blood cells, and platelets. Chemotherapy drugs can cause bone marrow suppression, which can result in anemia, leukopenia, and thrombocytopenia. These conditions can increase the risk of infection, bleeding, and fatigue. The nurse should compare the patient's blood counts with the normal values and the provider's orders and report any abnormalities or contraindications to the provider.
The nurse should review the serum electrolytes and blood urea nitrogen before administering chemotherapy to a patient who has lung cancer. The serum electrolytes measure the levels of sodium, potassium, chloride, and bicarbonate in the blood. The blood urea nitrogen measures the amount of urea nitrogen, a waste product of protein metabolism, in the blood. Chemotherapy drugs can cause nephrotoxicity, which can impair the kidney's function and cause electrolyte imbalance, dehydration, and metabolic acidosis. The nurse should compare the patient's serum electrolytes and blood urea nitrogen with the normal values and the provider's orders and report any abnormalities or contraindications to the provider.
The nurse should review the liver function tests and serum bilirubin before administering chemotherapy to a patient who has lung cancer. The liver function tests measure the levels of enzymes and proteins that reflect the liver's function, such as alanine aminotransferase (ALT), aspartate aminotransferase (AST), alkaline phosphatase (ALP), albumin, and total protein. The serum bilirubin measures the level of bilirubin, a pigment that is produced by the breakdown of red blood cells, in the blood. Chemotherapy drugs can cause hepatotoxicity, which can damage the liver cells and impair the liver's function. The nurse should compare the patient's liver function tests and serum bilirubin with the normal values and the provider's orders and report any abnormalities or contraindications to the provider.
All of the above laboratory tests are important to review before administering chemotherapy to a patient who has lung cancer. Chemotherapy drugs can cause various adverse effects that affect different organs and systems in the body. The nurse should monitor the patient's laboratory values closely and adjust the dosage or frequency of chemotherapy drugs as prescribed by the provider. The nurse should also provide supportive care and education to the patient to prevent or manage the adverse effects of chemotherapy.
Choice A reason:
The nurse should review the complete blood count and differential before administering chemotherapy to a patient who has lung cancer. The complete blood count and differential measure the number and types of blood cells, such as red blood cells, white blood cells, and platelets. Chemotherapy drugs can cause bone marrow suppression, which can result in anemia, leukopenia, and thrombocytopenia. These conditions can increase the risk of infection, bleeding, and fatigue. The nurse should compare the patient's blood counts with the normal values and the provider's orders and report any abnormalities or contraindications to the provider.
Choice B reason:
The nurse should review the serum electrolytes and blood urea nitrogen before administering chemotherapy to a patient who has lung cancer. The serum electrolytes measure the levels of sodium, potassium, chloride, and bicarbonate in the blood. The blood urea nitrogen measures the amount of urea nitrogen, a waste product of protein metabolism, in the blood. Chemotherapy drugs can cause nephrotoxicity, which can impair the kidney's function and cause electrolyte imbalance, dehydration, and metabolic acidosis. The nurse should compare the patient's serum electrolytes and blood urea nitrogen with the normal values and the provider's orders and report any abnormalities or contraindications to the provider.
Choice C reason:
The nurse should review the liver function tests and serum bilirubin before administering chemotherapy to a patient who has lung cancer. The liver function tests measure the levels of enzymes and proteins that reflect the liver's function, such as alanine aminotransferase (ALT), aspartate aminotransferase (AST), alkaline phosphatase (ALP), albumin, and total protein. The serum bilirubin measures the level of bilirubin, a pigment that is produced by the breakdown of red blood cells, in the blood. Chemotherapy drugs can cause hepatotoxicity, which can damage the liver cells and impair the liver's function. The nurse should compare the patient's liver function tests and serum bilirubin with the normal values and the provider's orders and report any abnormalities or contraindications to the provider.
Choice D reason:
All of the above laboratory tests are important to review before administering chemotherapy to a patient who has lung cancer. Chemotherapy drugs can cause various adverse effects that affect different organs and systems in the body. The nurse should monitor the patient's laboratory values closely and adjust the dosage or frequency of chemotherapy drugs as prescribed by the provider. The nurse should also provide supportive care and education to the patient to prevent or manage the adverse effects of chemotherapy.